Functionalized PMMA Microparticles

Functionalized, transparent polymer beads with a very narrow particle size distribution for particle analysis using flow cytometry or other screening applications.

It’s possible to custom modify beads with antibodies, oligonucleotides and peptides, respectively.

Contact Us For A Quote With The Form Below

Category: Micro- and Nanoparticles (beads) Tags: KF Technology, KFT, Microparticles, PMMA, Research, Scientific Research

Description

Functionalized PMMA Microparticles

Functionalized, transparent polymer beads with a very narrow particle size distribution for particle analysis using flow cytometry or other screening applications.

It’s possible to custom modify beads with antibodies, oligonucleotides and peptides, respectively.

Transparent, functionalized PMMA Microparticles

Id	Mean Diameter	Surface Modifications	Packaging Volume
105 01 002	2 µm	3D-Carboxy	4 mL
105 01 005	5 µm	3D-Carboxy	4 mL
105 01 009	9 µm	3D-Carboxy	4 mL
105 01 012	12 µm	3D-Carboxy	4 mL
105 01 016	16 µm	3D-Carboxy	4 mL
105 01 020	20 µm	3D-Carboxy	4 mL
105 01 037	37 µm	3D-Carboxy	4 mL
105 10 002	2 µm	Low Aggregation	4 mL
105 10 005	5 µm	Low Aggregation	4 mL
105 10 009	9 µm	Low Aggregation	4 mL
105 10 012	12 µm	Low Aggregation	4 mL
105 10 016	16 µm	Low Aggregation	4 mL
105 10 020	20 µm	Low Aggregation	4 mL
105 21 002	2 µm	Streptavidin	1.5 mL
105 21 005	5 µm	Streptavidin	1.5 mL
105 21 009	9 µm	Streptavidin	1.5 mL
105 21 012	12 µm	Streptavidin	1.5 mL
105 21 016	16 µm	Streptavidin	1.5 mL
105 21 020	20 µm	Streptavidin	1.5 mL
105 21 037	37 µm	Streptavidin	1.5 mL
105 22 002	2 µm	Neutravidin	1.5 mL
105 22 005	5 µm	Neutravidin	1.5 mL
105 22 009	9 µm	Neutravidin	1.5 mL
105 22 012	12 µm	Neutravidin	1.5 mL
105 22 016	16 µm	Neutravidin	1.5 mL
105 22 020	20 µm	Neutravidin	1.5 mL
105 22 037	37 µm	Neutravidin	1.5 mL
105 24 002	2 µm	3D-Alkyne	1.5 mL
105 24 005	5 µm	3D-Alkyne	1.5 mL
105 24 009	9 µm	3D-Alkyne	1.5 mL
105 24 012	12 µm	3D-Alkyne	1.5 mL
105 24 016	16 µm	3D-Alkyne	1.5 mL
105 24 020	20 µm	3D-Alkyne	1.5 mL
105 28 002	2 µm	Protein A/G	1.5 mL
105 28 005	5 µm	Protein A/G	1.5 mL
105 28 009	9 µm	Protein A/G	1.5 mL
105 28 012	12 µm	Protein A/G	1.5 mL
105 28 016	16 µm	Protein A/G	1.5 mL
105 28 020	20 µm	Protein A/G	1.5 mL
108 35 002	2 µm	3D-Azide	1.5 mL
108 35 005	5 µm	3D-Azide	1.5 mL
108 35 009	9 µm	3D-Azide	1.5 mL
108 35 012	12 µm	3D-Azide	1.5 mL
108 35 016	16 µm	3D-Azide	1.5 mL
108 35 020	20 µm	3D-Azide	1.5 mL
108 35 037	37 µm	3D-Azide	1.5 mL
108 36 002	2 µm	3D-Aldehyde	1.5 mL
108 36 005	5 µm	3D-Aldehyde	1.5 mL
108 36 009	9 µm	3D-Aldehyde	1.5 mL
108 36 012	12 µm	3D-Aldehyde	1.5 mL
108 36 016	16 µm	3D-Aldehyde	1.5 mL
108 36 020	20 µm	3D-Aldehyde	1.5 mL
108 36 037	37 µm	3D-Aldehyde	1.5 mL

Selected Publications and References

E. Hemmig, Y. Temiz, O. Gökçe, R. D. Lovchik, E. Delarmarche: Transposing lateral flow immunoassays to capillary-driven microfluidics using self-coalescence modules and capillary-assembled receptor carriers, 2020, Analytical Chemistry 92(1), 940-946.
A. L. Wooster, T. S. Anderson, D. B. Lowe: Expression and characterization of solubleepitope-defined major histocompatibility complex (MHC) from stable eukaryotic cell lines, 2019, Journal of Immunological Methods 464, 22-30.

Contact Us For A Quote